Feb. 1 at 3:36 AM
Congrats to everyone who invested in
$IKTO is seeing great results! Up next,
$VTGN is moving forward in Phase 3 with fasedienol, a nasal spray for social anxiety. PALISADE-3 and 4 are testing its effectiveness in reducing anxiety during public speaking challenges, showing fast and promising results